Niki BioSolutions, Inc. (NIKI) Share-based Compensation (2023 - 2025)
Niki BioSolutions' (NIKI) quarterly Share-based Compensation came in at $1.1 million in Q4 2025, up 18624.74% YoY from N/an in Q4 2024, and little changed on a QoQ basis from $1.1 million in Q2 2025.
Niki BioSolutions, Inc. (NIKI) Share-based Compensation (2023 - 2025) Analysis & Trends
Niki BioSolutions (NIKI) has 3 years of Share-based Compensation data on file, last reported at $1.1 million in Q4 2025.
- Quarterly Share-based Compensation rose 18624.74% year-over-year to $1.1 million in Q4 2025, while the trailing twelve-month figure through Nov 2025 was $1.1 million (changed N/A YoY) and the FY2025 annual result came in at $153189.0, down 21.38% from the prior year.
- Share-based Compensation steadied at $1.1 million in Q4 2025, from $1.1 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $1.1 million in Q2 2025 to a low of -$888082.0 in Q2 2023.
- A 3-year average of $263952.0 and a median of $14577.0 in 2024 frame the typical range for Share-based Compensation.
- The widest YoY moves for Share-based Compensation: up 18624.74% in 2025, down 18624.74% in 2025.
- Tracing NIKI's Share-based Compensation over 3 years: stood at -$888082.0 in 2023, then soared by 100.66% to $5841.0 in 2024, then jumped by 18624.74% to $1.1 million in 2025.
- The last three Share-based Compensation figures came in at $1.1 million (Q4 2025), $1.1 million (Q2 2025), and $5841.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2025 | 1.09 Mn |
| Nov 30, 2025 | 1.09 Mn |
| May 31, 2025 | 1.09 Mn |
| May 31, 2025 | 1.09 Mn |
| Nov 30, 2024 | 5,841.00 |
| Nov 30, 2024 | 5,841.00 |
| Aug 31, 2024 | 14,577.00 |
| Aug 31, 2024 | 14,577.00 |
| Jun 30, 2023 | -888,082.00 |
| Jun 30, 2023 | -888,082.00 |